Introduction
============

Saliva is formed mainly by the secretion of salivary glands. This fluid is essential for the homeostasis of the oral cavity, since it cleans, lubricates and protects the oral tissues, as well as acting as a buffering agent and source of calcium and phosphate ions for remineralization of the teeth.^[@B1]^ Moreover, saliva is the major contributor for the protein composition of the acquired enamel pellicle (AEP), a bacteria-free organic layer formed by the selective adsorption of salivary proteins on the surface of the enamel,^[@B2]^ but containing also carbohydrates, neutral lipids, phospholipids and glycolipids.^[@B3]-[@B5]^ These organic components grant important functions to the AEP that acts as a diffusion barrier, reducing the direct contact of the acids with the tooth surface, slowing down tooth dissolution.^[@B1],[@B6],[@B7]^

The ability of the AEP to protect the enamel surface against acids is due mainly to its protein composition, especially by the proteins present in the basal layer. These remain in the AEP after exposure to acids^[@B8]^ and are currently objects of great interest, since they might protect against dental caries and erosion. In the last few years, proteomic approaches have been used to identify these proteins^[@B9]-[@B12]^ so that they can be added to dental products which, when applied, could modify the composition of the AEP, increasing its protective potential against acids.^[@B13]^

One of the main difficulties faced in the studies involving proteomic analysis of the AEP is the small amount of proteins that can be obtained, which can impair analysis, both in *in vitro, in situ* and *in vivo*. The amount of proteins that can be recovered is even smaller under *in vitro* condition, due to the absence of continuous salivary flow. Moreover, in the *in vivo* studies available so far, AEP samples collected from 8-10 volunteers are pooled in order to obtain enough proteins to be analyzed by mass spectrometry,^[@B10]-[@B12],[@B14]-[@B18]^ which does not allow proper assessment of the biological variation of the samples. In these *in vivo* studies, the collection of the AEP samples is done with filter paper soaked in 3% citric acid.

Recently, the proteome of the acquired pellicle formed *in situ* on ceramic specimens and collected by incubation in Tris-HCl buffer containing Triton X-100 followed by ultrasonication in RIPA buffer was analyzed from individual volunteers, with high inter-individual and inter-day consistency.^[@B19]^ However, the protocol of collection of the AEP employed by Delius 2017^[@B19]^ is not viable to be employed *in vivo*, since Triton X-100 is toxic and sonication is not possible. In addition, 0.5% dodecyl sodium sulphate (SDS) has been employed for the collection of AEP samples for analysis of individual proteins by immunoblotting,^[@B20]^ but SDS was not tested for collection of AEP samples for proteomic analyses yet.

Thus, the aim of this study was to develop an *in vitro* AEP formation protocol comparing different collection solutions for shotgun proteomic analysis. The solutions tested (3% citric acid and 0.5% SDS, alone or in combination) were chosen based on their potential to be employed under *in vivo* conditions, which would allow individual analysis and better assessment of biological variation among the volunteers in future studies.

Methodology
===========

Ethical aspects and subjects
----------------------------

This study was approved by the local Ethics Committees (Human and Animal, protocols 86772718.0.0000.5417 and 007/2018, respectively) of Bauru School of Dentistry, University of São Paulo, SP, Brazil).

Nine young adult subjects of both genders took part in the study, after signing an informed consent document. The exclusion criteria for the volunteers were: presence of caries lesions, use of medication that could change the salivary flow, gingivitis, smoking habit, periodontitis, low salivary flow (unstimulated and stimulated flows should be greater than 0.1 and 1.0 mL/minute, respectively).

The volunteers received a kit containing a toothbrush, toothpaste and floss for oral hygiene standardization. In the morning (to avoid circadian effects),^[@B21]^ after oral hygiene (2 hours), unstimulated saliva was collected from each volunteer in tubes, kept in ice. Saliva samples were immediately centrifuged (4.500 x*g* at 4°C, 15 min). The supernatants were collected, pooled and added to a 1:100 protease inhibitor (phenylmethane sulfonyl fluoride - PMSF, N-Ethyhlmaleimide - NEM and Phenantroline).^[@B9]^ Saliva supernatants were stored at -80ºC, until use.

Preparation of bovine specimens
-------------------------------

Bovine incisors underwent a process of screening and cleaning (removal of soft tissue) before preparation. Each tooth was glued on an acrylic plate with thermoactive dental plaster (Kerr Corporation, Orange, CA, EUA) for the separation of the root and coronary portions. The crowns were cut using a precision cutting machine (ISOMET Low Speed Saw Buehler Ltd., Lake Bluff, IL, EUA), with two diamond discs (double-sided XL 12205 'high concentration', 102 × 12.7 × 0.3 mm^3^; Extec Diamont Wafering Blade, Enfield, CT, USA) separated by a 4-mm thick spacer, in order to obtain 4 × 4 × 2 mm enamel specimens.

Study groups
------------

A total of 432 standardized bovine enamel specimens were obtained and divided into four groups (n=108/group), according to the solution used to collect the AEP, as follows: 1) 3% citric acid (CA)^[@B16]^; 2) 0.5% sodium lauryl sulfate (SDS)^[@B20]^; 3) CA followed by SDS (CA+SDS); 4) SDS followed by CA (SDS+CA).

Formation of AEP *in vitro*
---------------------------

For the formation of the AEP, the specimens were placed in 96-well microplates in which 250 µL of saliva were added. The AEP was then allowed to form for 120 min. For the constant control of the temperature and agitation, a ThermoMixer^®^ (Eppendorf ThermoMixer^®^ C, Hamburg, Germany) was used at 37°C, under agitation. The mainly particularity in this study was the new methodology adopted regarding the resupply of saliva. For this, during the AEP formation (120 min), saliva was exchanged three times (every 30 min). This way, the previous saliva was removed and a new sample was immediately added (250 µL).

Collection of the AEP
---------------------

After the formation of AEP, the specimens were immediately withdrawn from saliva and washed with a small spray of deionized water for three seconds and air dried. The AEP was collected using an electrode filter paper 5 × 10 mm (Electrode Wick, Bio-Rad, Hercules, CA, USA) soaked in the collection solutions according with the respective group. The excess of the acid was removed with absorbent paper. For CA+SDS and SDS+CA groups, one filter paper was used for the first solution and a new filter paper was used for the second one. One filter paper was used for 6 specimens only and then resupplied by a new one.

For AEP collection, each paper soaked with their respective solution was rubbed (no pressure) on the enamel surface, with the aid of tweezers.^[@B16]^ The filter papers used to collect AEP from the specimens of the same group were placed in 2 mL tubes and stored at -80°C. The experiment was repeated for additional 2 consecutive days.

Shotgun proteomics analysis by NanoLC-ESI-MS/MS
-----------------------------------------------

The methods were exactly as described elsewhere.^[@B17]^ The papers with the samples were cut into small pieces with the aid of sterile scissors and tweezers. The filter papers containing the AEP collected from 3 different days (triplicate collection) for each of the groups were pooled to obtain enough amount of AEP proteins to be submitted to the proteomic analysis.

The peptides identification was performed on a nanoACQUITY UPLC-Xevo QTof MS system (Waters, Manchester, UK). In addition, ProteinLynx Global Server (PLGS) version 3.0 was used to process and search the continuum LC-MSE data. Samples from each group were analyzed in triplicate (technical triplicates). Proteins were searched for on the *Homo sapiens* proteome database (reviewed only, UniProtKB/Swiss-Prot) downloaded on April 2017 from UniProtKB (http://www.uniprot.org/).^[@B17]^

Finally, the identified proteins were classified and assigned by biological function,^[@B18],\ [@B22]^ origin and molecular interaction (http://www.uniprot.org/) ([Table S1](#t1){ref-type="table"}).

Table S1Classification of proteins from the acquired pellicle collected *in vitro* represented in each groupAccession numberProtein NameScoreCASLSCA + SLSSLS + CAP68032Actin\_ alpha cardiac muscle 1 (d, m, n, q, u, w)65.6055X  xP68133Actin\_ alpha skeletal muscle (b, d, m, n, q, u, w)65.6055X  xP62736Actin\_ aortic smooth muscle (b, d, m, n, q, u)65.6055X  xP60709Actin\_ cytoplasmic 1 (b, m, n, q, u, w)65.6055X  xP63261Actin\_ cytoplasmic 2 (a, d, g, j, n, q, u, w)65.6055X  xP63267Actin\_ gamma-enteric smooth muscle (b, m, n, q, u, w)65.6055X  xP04745Alpha-amylase 1 (a, g, o, u)452.4455XxxxP19961Alpha-amylase 2B (a, g, o, u)579.3912XxxxG5E9X6Basic salivary proline-rich protein 1 (b, l, o, u)155.8623X xxP02812Basic salivary proline-rich protein 2 (b, l, o, u)155.8623X xxQ562R1Beta-actin-like protein 2 (b, m, n, u, w)78.1257X  xQ96RL1BRCA1-A complex subunit RAP80 (d, m, p, u)47.3122X   P38398Breast cancer type 1 susceptibility protein (b, e, m, n, p, u)85.8217X   Q8N4G4CA6 protein (a,m,t,u)76.7328 xxxP23280Carbonic anhydrase 6 (a, g, o, u)301.6657XxxxQ9BXL7Caspase recruitment domain-containing protein 11(c, e, m, n, s, w)60.8839X   P08603Complement factor H (b, m, o, u)38.0628  x Q03591Complement factor H-related protein 1 (a, m, o, w)38.0628  x P01036Cystatin-S (a, b, g, o, u)2640.733XxxxP09228Cystatin-SA (a, b, g, o, u)451.4857xxxxP01037Cystatin-SN (a, b, g, o, u)2646.624xxxxQ9UGM3Deleted in malignant brain tumors 1 protein (f, m, n, o, v, w)86.0094xxxxO75928E3 SUMO-protein ligase PIAS2 (e, m, p, u)24.2121  x Q9NRM1Enamelin (b, d, m, o, w)15.9628  x P68871Hemoglobin subunit beta (b, c, m, n, o, u, w)293.9594 x xP02042Hemoglobin subunit delta (b, c, m, n, o, u, w)293.9594 x xP02100Hemoglobin subunit epsilon (b, c, m, n, u)293.9594 x xP69891Hemoglobin subunit gamma-1(b, c, h, n, o, u, w)293.9594 x xP69892Hemoglobin subunit gamma-2 (b, c, m, n, u)293.9594 x xP01876Immunoglobulin heavy constant alpha 1 (b, e, i, j, o, u)866.7542xxxxP01877Immunoglobulin heavy constant alpha 2 (b, e, i, j, o, u)806.5165xxxxP01591Immunoglobulin J chain (a, b, m, o, w)946.0537   xQ8WYH8Inhibitor of growth protein 5 (b, m, p, u)95.4649  x Q9H1B7Interferon regulatory factor 2-binding protein-like (b, m, p, u)9.3029   xP31025Lipocalin-1 (a, b, m, o, w)623.5907xxxxP61626Lysozyme C (a, b, g, i, j, o, u, w)268.2844xxxxQ8TAX7Mucin-7 (b, i, k, o, u)417.1399x x C9JTN7Nucleolysin TIA-1 isoform p40 (b,m,n,x)92.8821x   P04746Pancreatic alpha-amylase (a, g, o, u)1996.417xxxxQ6S8J3POTE ankyrin domain family member E (b, m, o, u)65.6055x  xA5A3E0POTE ankyrin domain family member F (b, m, o, u)65.6055x  xP0CG38POTE ankyrin domain family member I (b, m, o, u)69.466   xP0CG39POTE ankyrin domain family member J (b, m, o, u)69.466   xA0A0A0MT31Proline-rich protein 4 (b, l, p, u)420.9096x xxP06702Protein S100-A9 (a, b, g, i, j, n, o, q, s, u, w)711.9667x  xQ9BYX7Putative beta-actin-like protein 3 (a, m, n, q, u, w)65.6055x  xQ5VSP4Putative lipocalin 1-like protein 1 (b, m, o, x)204.5444xxxxP02810Salivary acidic proline-rich phosphoprotein 1/2 (b, d, h, l, o, u, v)420.9096x xxQ8NBW4Sodium-coupled neutral amino acid transporter 9 (f, m, r, u, w)255.0823x   Q86WA9Sodium-independent sulfate anion transporter (c, m, s, u)262.1345x   P02808Statherin (b, e, i, l, o, u)54090.52xxxxP02814Submaxillary gland androgen-regulated protein 3B (a, g, o, u, w)3959.276xxxxP17987T-complex protein 1 subunit alpha (e, m, n, w)59.5312x   A0A087WZY1Uncharacterized protein (m, t, x)420.9096x xxP25311Zinc-alpha-2-glycoprotein (a, b, g, o, u, w)496.7979x   [^2]

Results
=======

The total amount of AEP proteins recovered was very similar for all the groups, ranging between 26 and 33 µg. A total of 55 proteins were identified ([Figure 1](#f01){ref-type="fig"}), among which are 20 proteins typically found in the AEP, such as two isoforms of Alpha-amylase, two isoforms of Basic salivary proline-rich protein, three isoforms of Cystatin, five isoforms of Hemoglobin, *Lysozyme, Mucin-7, Pancreatic alpha-amylase, Proline-rich protein 4, Protein S100-A9, Salivary acidic proline-rich phosphoprotein ½, Statherin and Submaxillary gland androgen-regulated protein 3B* ([Table S1](#t1){ref-type="table"}).

Figure 1Venn Diagram with the numbers of the exclusive proteins from each group and the proteins common to two or more group

The total numbers of proteins identified in each group were 40, 21, 28 and 41 for CA, SDS, CA+SDS and SDS+CA, respectively. Among them, 15, 14, 14 and 9 are proteins typically found in the AEP ([Table 1](#t2){ref-type="table"}). Additionally, the proteins found exclusively in one of the groups was 8, 0, 5 e 4 for the groups CA, SDS, CA+SDS and SDS+CA, respectively ([Table 1](#t2){ref-type="table"}; [Figure 1](#f01){ref-type="fig"}).

Table 1Proteins identified in the acquired enamel pellicle formed *in vitro* on enamel specimens and collected using different solutionsGroupAccession numberProtein NameScore**CA**P68032Actin\_ alpha cardiac muscle 165.6055 P68133Actin\_ alpha skeletal muscle65.6055 P62736Actin\_ aortic smooth muscle65.6055 P60709Actin\_ cytoplasmic 165.6055 P63261Actin\_ cytoplasmic 265.6055 P63267Actin\_ gamma-enteric smooth muscle65.6055 P04745**Alpha-amylase 1**452.4455 P19961**Alpha-amylase 2B**579.3912 G5E9X6**Basic salivary proline-rich protein 1**155.8623 P02812**Basic salivary proline-rich protein 2**155.8623 Q562R1Beta-actin-like protein 278.1257 Q96RL1\*BRCA1-A complex subunit RAP8047.3122 P38398\*Breast cancer type 1 susceptibility protein85.8217 P23280Carbonic anhydrase 6144.9005 Q9BXL7\*Caspase recruitment domain-containing protein 1160.8839 P01036**Cystatin-S**2640.733 P09228**Cystatin-SA**451.4857 P01037**Cystatin-SN**2646.624 Q9UGM3Deleted in malignant brain tumors 1 protein86.0094 P01876Immunoglobulin heavy constant alpha 1866.7542 P01877Immunoglobulin heavy constant alpha 2806.5165 P31025Lipocalin-1623.5907 P61626**Lysozyme C**268.2844 Q8TAX7**Mucin-7**417.1399 C9JTN7\*Nucleolysin TIA-1 isoform p4092.8821 P04746**Pancreatic alpha-amylase**1996.417 Q6S8J3POTE ankyrin domain family member E65.6055 A5A3E0POTE ankyrin domain family member F65.6055 A0A0A0MT31**Proline-rich protein 4**420.9096 P06702**Protein S100-A9**711.9667 Q9BYX7Putative beta-actin-like protein 365.6055 Q5VSP4Putative lipocalin 1-like protein 1204.5444 P02810**Salivary acidic proline-rich phosphoprotein 1/2**420.9096 Q8NBW4\*Sodium-coupled neutral amino acid transporter 9255.0823 Q86WA9\*Sodium-independent sulfate anion transporter262.1345 P02808**Statherin**54090.52 P02814**Submaxillary gland androgen-regulated protein 3B**3959.276 P17987\*T-complex protein 1 subunit alpha59.5312 A0A087WZY1Uncharacterized protein420.9096 P25311\*Zinc-alpha-2-glycoprotein496.7979**SDS**P04745**Alpha-amylase 1**274.6967 P19961**Alpha-amylase 2B**274.6967 Q8N4G4CA6 protein76.7328 P23280Carbonic anhydrase 6301.6657 P01036**Cystatin-S**293.6917 P09228**Cystatin-SA**216.0704 P01037**Cystatin-SN**274.2227 Q9UGM3Deleted in malignant brain tumors 1 protein56.2783 P68871**Hemoglobin subunit beta**293.9594 P02042**Hemoglobin subunit delta**293.9594 P02100**Hemoglobin subunit epsilon**293.9594 P69891**Hemoglobin subunit gamma-1**293.9594 P69892**Hemoglobin subunit gamma-2**293.9594 P01876**Immunoglobulin heavy constant alpha 1**290.1472 P01877**Immunoglobulin heavy constant alpha 2**9.2098 P31025Lipocalin-11070.104 P61626**Lysozyme C**731.9259 P04746**Pancreatic alpha-amylase**36.6661 Q5VSP4Putative lipocalin 1-like protein 11070.104 P02808**Statherin**20250.94 P02814**Submaxillary gland androgen-regulated protein 3B**1497.902**CA+SDS**P04745**Alpha-amylase 1**181.0646 P19961**Alpha-amylase 2B**166.898 G5E9X6**Basic salivary proline-rich protein 1**552.4909 P02812**Basic salivary proline-rich protein 2**552.4909 Q8N4G4CA6 protein67.728 Q8N4G4CA6 protein47.9429 P23280Carbonic anhydrase 6728.2514 P08603\*Complement factor H38.0628 Q03591\*Complement factor H-related protein 138.0628 P01036**Cystatin-S**1556.063 P09228**Cystatin-SA**1013.174 P01037**Cystatin-SN**205.9523 Q9UGM3Deleted in malignant brain tumors 1 protein118.9028 O75928\*E3 SUMO-protein ligase PIAS224.2121 Q9NRM1\*Enamelin15.9628 P01876Immunoglobulin heavy constant alpha 1154.7424 P01877Immunoglobulin heavy constant alpha 279.6826 Q8WYH8\*Inhibitor of growth protein 595.4649 P31025Lipocalin-11275.895 P61626**Lysozyme C**1199.526 Q8TAX7**Mucin-7**93.5897 P04746**Pancreatic alpha-amylase**166.898 A0A0A0MT31**Proline-rich protein 4**325.6618 Q5VSP4Putative lipocalin 1-like protein 11275.895 P02810**Salivary acidic proline-rich phosphoprotein 1/2**325.6618 P02808**Statherin**32088.14 P02814**Submaxillary gland androgen-regulated protein 3B**1053.619 A0A087WZY1Uncharacterized protein325.6618**SDS+CA**P68032Actin\_ alpha cardiac muscle 1145.4612 P68133Actin\_ alpha skeletal muscle145.4612 P62736Actin\_ aortic smooth muscle145.4612 P60709Actin\_ cytoplasmic 1145.4612 P63261Actin\_ cytoplasmic 2145.4612 P63267Actin\_ gamma-enteric smooth muscle145.4612 P04745**Alpha-amylase 1**3352.857 P19961**Alpha-amylase 2B**3008.341 G5E9X6**Basic salivary proline-rich protein 1**174.755 P02812**Basic salivary proline-rich protein 2**174.755 Q562R1Beta-actin-like protein 272.3325 Q8N4G4CA6 protein48.5939 P23280Carbonic anhydrase 6836.3896 P01036**Cystatin-S**1501.204 P09228**Cystatin-SA**657.3894 P01037**Cystatin-SN**1529.473 Q9UGM3Deleted in malignant brain tumors 1 protein233.5314 P68871**Hemoglobin subunit beta**761.2395 P02042**Hemoglobin subunit delta**761.2395 P02100**Hemoglobin subunit epsilon**761.2395 P69891**Hemoglobin subunit gamma-1**761.2395 P69892**Hemoglobin subunit gamma-2**761.2395 P01876**Immunoglobulin heavy constant alpha 1**621.9611 P01877**Immunoglobulin heavy constant alpha 2**182.5975 P01591\*Immunoglobulin J chain946.0537 Q9H1B7\*Interferon regulatory factor 2-binding protein-like9.3029 P31025Lipocalin-11312.528 P61626**Lysozyme C**4389.076 P04746**Pancreatic alpha-amylase**3061.443 Q6S8J3POTE ankyrin domain family member E117.0785 A5A3E0POTE ankyrin domain family member F117.0785 P0CG38\*POTE ankyrin domain family member I69.466 P0CG39\*POTE ankyrin domain family member J69.466 A0A0A0MT31**Proline-rich protein 4**368.7032 P06702**Protein S100-A9**132.0728 Q9BYX7Putative beta-actin-like protein 347.6124 Q5VSP4Putative lipocalin 1-like protein 11295.604 P02810**Salivary acidic proline-rich phosphoprotein 1/2**368.7032 P02808**Statherin**32670.96 P02814**Submaxillary gland androgen-regulated protein 3B**1295.599 A0A087WZY1Uncharacterized protein368.7032[^3]

Fifteen proteins were identified in all groups ([Figure 1](#f01){ref-type="fig"}), most of them being proteins typically described in the AEP, such as *Pancreatic alpha-amylase, Submaxillary gland androgen-regulated protein 3B, Immunoglobulin heavy constant alpha 1, Immunoglobulin heavy constant alpha 2*, two isoforms of Alpha-amylase, three isoforms of Cystatin, *Lysozyme C* and *Statherin* ([Table S1](#t1){ref-type="table"}).

Remarkably, *Mucin-7* was only identified in the CA and CA+SDS groups, while *Protein S100-A9* was only found in the CA and SDS+CA groups. On the other hand, isoforms of *Hemoglobin* were only detected in the SDS and SDS+CA groups. Moreover, a typical enamel protein*, Enamelin*, was identified in the CA+SDS group only. Furthermore, 3 types of PRP were not found in the SDS group ([Table S1](#t1){ref-type="table"}).

Discussion
==========

The proteomic analysis of AEP formed *in vitro* is an important tool in pre-clinical studies since it allows preliminary evaluation of preventive agents for dental caries and dental erosion. In addition, in *in vitro* studies it is possible to recover the enamel specimens over which the AEP is formed to be submitted to distinct tests, which is not feasible *in vivo*. However, to date there is only one study where the proteomic profile of the AEP formed *in vitro* was evaluated.^[@B25]^ In this sense, our main aim was to develop an *in vitro* protocol of the AEP formation using different solutions previously described in the literature to collect AEP proteins for shotgun proteomic analysis.

The main reason for such scarcity of studies is the small amount of proteins that can be recovered from the *in vitro* formed AEP, whereas that in *in vivo* condition the AEP is formed under continuous salivary flow, which is not present *in vitro*. In order to overcome this, in this study we resupplied the saliva in which the specimens were immersed every 30 min during the two-hour period of AEP formation. This procedure was successful for an *in vitro* study, since it allowed recovery of approximately 30 µg of proteins that is enough for proper proteomic analysis. In contrast, pilot studies performed for the definition of this protocol with the absence of saliva exchange demonstrated the failure in the recovery proteins of the AEP (data not shown). Despite the fact that saliva was resupplied every 30 to increase the total amount of recovered proteins, it is possible that the solution used to collect the AEP proteins may also influence the amount of recovered proteins.

To date, most of the studies available in the literature employ 3% citric acid for collected of the acquired pellicle.^[@B9]-[@B11],[@B14]-[@B18],[@B23]-[@B25]^ However, in these studies, the proteins collected from 8-10 volunteers are pooled in order to obtain enough amount of proteins to be analyzed by mass spectrometry, i.e., it is not possible to perform individual analysis. More recently, the pellicle proteins formed on ceramic specimens *in situ* were eluted by incubation in TRIS-HCl buffer containing SDS, followed by ultrasonication in RIPA-buffer. This procedure allowed analysis of individual samples with high inter-individual and inter-day consistency.^[@B19]^ However, it cannot be done *in vivo*, due to the necessity of sonication and to the toxicity of the detergents employed. SDS has been employed to collection AEP proteins *in vivo* in order to perform immunoblotting analysis.^[@B20]^ Since SDS is biocompatible and can be used to collected AEP proteins *in vivo*, in the present study we evaluated both 3% citric acid and 0.5% SDS, alone or in combination, in order to develop a method of collection of AEP proteins that results in large amount of proteins and can be employed in different protocols (*in vitro, in situ* and *in vivo*).

The obtained results indicate that the amount of proteins (ranging between 26 and 33 µg) recovered when these solutions were used was satisfactory, especially considering an *in vitro* study. Moreover, among the 55 proteins identified in all groups, 15 are common to all of them, most of which are classical players of the AEP. It could be expected that the combinations CA + SDS or SDS + CA could increase the total number of identified proteins, in comparison to CA or SDS only, since the acid and the detergent could be expected to remove different proteins of the AEP. However, this was not the case, since the total number of identified proteins were 40, 21, 28 and 41 for CA, SDS, CA + SDS and SDS + CA groups, respectively. It is also important to consider the quality of the identified proteins. Mucin included among the pellicle precursors^[@B25]^ and associated with lubrication^[@B3]^ and protection against erosive challenges^[@B26]^ was only identified in the CA and CA + SDS groups. This means that the use of SDS first might not remove this protein. Moreover, Enamelin, a typical enamel protein, was identified only in the CA + SDS group, indicating that this combination might remove a layer of enamel.

Thus, the results obtained indicate that the new technique develop by resupply of saliva for the AEP formation in the present study was essential for a higher number of the proteins identified by proteomics analysis. In addition, 3% citric acid is, among the tested solutions, the best one to remove AEP proteins for shotgun proteomic analysis. The amounts and quality of proteins recovered when 3% citric acid was used is satisfactory, especially considering the *in vitro* protocol of this study. Moreover, the amount of proteins recovered when CA was used (around 30 µg) might be enough to allow proteomic analysis of biological triplicates, since not assessing the biological variability is currently the major shortcoming of the proteomic studies of the AEP. It would be desirable to compare the proteomic profile of AEPs formed *in vitro, in situ* and *in vivo*, so that the results of *in vitro* and *in situ* studies can be extrapolated to the clinical condition.
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